|
Mr. Mathews has worked on a variety of projects for reimbursement involving the analysis of coding, coverage, and payment issues. His specific area of expertise is in diagnostics with a focus on laboratory reimbursement systems and molecular diagnostics. Mr. Mathews has been the driving force behind identifying public and private payer coverage channels for both drugs and medical devices. His experience includes laboratory reimbursement systems, value based pricing for drug/diagnostic combinations, and pharmaceutical product launches. Mr. Mathews’ prior experience includes working on health policy as a legislative aide on Capitol Hill. He has also worked for the government affairs office of Genentech and has worked a National Institutes of Health sponsored clinical trail which focused on genetic testing for Alzheimer’s disease. Mr. Mathews has a Masters degree in public policy from Duke University and completed his undergraduate work at Colgate University. | 